FDA Orders Blindness Warning on Ozempic, Wegovy and Other GLP-1 Drugs Over Rare Eye Condition NAION
US regulators say GLP-1 weight-loss and diabetes drugs carry an increased risk of rare NAION events, a painless optic nerve condition that can permanently reduce vision in one eye.